These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 5039620)

  • 21. [Characteristics of antilymphocyte sera in serologic and cytotoxic tests with primary and secondary immune response].
    Musiĭ IL; Montag TS; Bezverkhiĭ VD; Chernyĭ VA; Dedkov IP
    Patol Fiziol Eksp Ter; 1972; 16(1):10-6. PubMed ID: 5040054
    [No Abstract]   [Full Text] [Related]  

  • 22. A lymphocyte cytotoxicity rebound phenomenon induced by enhancing sera.
    Debray-Sachs M; Soucy PE; Hamburger J
    J Immunol; 1973 Mar; 110(3):661-6. PubMed ID: 4569798
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of colostral passive immunity in calves on anti-foot-and-mouth disease vaccination results].
    Wisniewski J; Jankowska J
    Bull Off Int Epizoot; 1972; 77(5):745-53. PubMed ID: 4660709
    [No Abstract]   [Full Text] [Related]  

  • 24. The termination of immunologic unresponsiveness to BSA in rabbits by transfer of normal sibling thymocytes.
    Benjamin DC
    J Immunol; 1974 Nov; 113(5):1589-92. PubMed ID: 4424553
    [No Abstract]   [Full Text] [Related]  

  • 25. Antilymphocytic activity of rabbit anti-chicken anti-brain sera.
    Feiglová E; Pichlíková L; Nouza K
    Folia Biol (Praha); 1972; 18(4):256-63. PubMed ID: 5054348
    [No Abstract]   [Full Text] [Related]  

  • 26. Migration of lymph node cells during the primary immune response.
    Cochran AJ; Klein E; Petranyi G
    Transplantation; 1971 Dec; 12(6):523-5. PubMed ID: 5120097
    [No Abstract]   [Full Text] [Related]  

  • 27. [Peculiarities of the structure of lymph nodes and distribution of immunocompetent cells in them in guinea pigs immunized with anatoxin in Freund's adjuvant].
    Lebedev KA; Ryzhova OS
    Patol Fiziol Eksp Ter; 1969; 13(2):26-31. PubMed ID: 5382859
    [No Abstract]   [Full Text] [Related]  

  • 28. Specificity of the immunosuppression caused by passive administration of antibody.
    Cerottini JC; McConahey PJ; Dixon FJ
    J Immunol; 1969 Aug; 103(2):268-75. PubMed ID: 5803786
    [No Abstract]   [Full Text] [Related]  

  • 29. The proliferative and anamnestic antibody response of rabbit lymphoid cells in vitro. II. Effect of passive antibody on immunologic memory in lymph nodes contralateral to the site of antigen injection.
    Thorbecke GJ; Bell MK
    J Immunol; 1973 Oct; 111(4):1043-7. PubMed ID: 4728672
    [No Abstract]   [Full Text] [Related]  

  • 30. The effect of anti-lymphocytic antibody on the development of experimental thyroiditis in rats induced by the intra-lymph node injection of rat thyroglobulin in Freund's complete adjuvant.
    Kalden JR; James K
    Immunology; 1971 Mar; 20(3):269-75. PubMed ID: 5551352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Model for central suppression of immune responsiveness in passive immunological enhancement.
    McKearn TJ; Fitch FW; Stuart FP
    Surg Forum; 1973; 24():311-13. PubMed ID: 4549407
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of protection from systemic infection or disease afforded by low to intermediate titers of passively acquired neutralizing antibody against bovine viral diarrhea virus in calves.
    Bolin SR; Ridpath JF
    Am J Vet Res; 1995 Jun; 56(6):755-9. PubMed ID: 7653884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Passive enhancement of homozygous renal allografts in the rat.
    Fabre JW; Morris PJ
    Transplantation; 1974 Nov; 18(5):429-35. PubMed ID: 4610921
    [No Abstract]   [Full Text] [Related]  

  • 34. Competence of thoracic duct cells in the transfer of adjuvant disease and delayed hypersensitivity. Evidence that mycobacterial components are required for the successful transfer of the disease.
    Quagliata F; Phillips-Quagliata JM
    Cell Immunol; 1972 Jan; 3(1):78-87. PubMed ID: 4621537
    [No Abstract]   [Full Text] [Related]  

  • 35. Induction of aspermatogenesis by passive transfer of immune sera or cells.
    Willson JT; Jones N; Katsh S
    Int Arch Allergy Appl Immunol; 1972; 43(2):172-81. PubMed ID: 5079522
    [No Abstract]   [Full Text] [Related]  

  • 36. Enhancing antibody. 3. Site of activity.
    Zimmerman B; Feldman JD
    J Immunol; 1970 Mar; 104(3):626-32. PubMed ID: 4907989
    [No Abstract]   [Full Text] [Related]  

  • 37. In vitro studies of cell-mediated immunity. I. Induction of lymphocyte transformation by a soluble "mitogenic" factor derived from interaction of sensitized guinea-pig lymphoid cells with specific antigen.
    Wolstencroft RA; Dumonde DC
    Immunology; 1970 Apr; 18(4):599-610. PubMed ID: 5421038
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of antilymphocyte sera by cross immunization of chimpanzees and baboons.
    Schwartz A; St Pierre RL; Madura JA; Lang RW
    Proc Soc Exp Biol Med; 1973 Jul; 143(3):816-23. PubMed ID: 4198166
    [No Abstract]   [Full Text] [Related]  

  • 39. Antigen-induced refractory period of adoptive transfer.
    Rose NR; Twarog FJ
    Transplant Proc; 1969 Mar; 1(1):564-6. PubMed ID: 5408711
    [No Abstract]   [Full Text] [Related]  

  • 40. [Functional change electrophoretic mobility of immun-competent cells].
    Jenssen HL; Köhler H; Huckstorf C
    Acta Biol Med Ger; 1974; 32(1):107-11. PubMed ID: 4471822
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.